Surgical Science Sweden AB (publ) (SUSRF)

Market Cap	814.60M
Revenue (ttm)	94.30M
Net Income (ttm)	14.06M
Shares Out	n/a
EPS (ttm)	0.27
PE Ratio	57.95
Forward PE	32.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Average Volume	2,124
Open	15.10
Previous Close	16.33
Day's Range	15.10 - 15.10
52-Week Range	11.30 - 16.33
Beta	0.63
RSI	54.43
Earnings Date	Aug 21, 2025

About SUSRF

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 274
• Stock Exchange: OTCMKTS
• Ticker Symbol: SUSRF

Financial Performance

In 2024, SUSRF's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial numbers in SEK